Contact Us

Get in Touch

Please enter your information in the form for general inquiries or to contact sales.

Additional contact information is listed below.

By submitting your information, you confirm you would like to be contacted by Acarix. Read our privacy notice here, if you want to know more about how we treat and protect your personal data.

Our Offices

Other Contacts

Media Relations

Jennifer Anderson
Head of Marketing & Communications
+1 720 471 4625

Frequently Asked Questions

You may be able to find the information you need amongst the frequently asked questions.

Go to FAQs
About Acarix

Acarix is a Swedish medical device company that innovates solutions for rapid rule out of coronary artery disease (CAD) at point of care.

The CE-approved and FDA DeNovo-cleared Acarix CADScor System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive, and costly diagnostic procedures.2

The CADScor System has been used on more than 29,000 patients.3 Acarix recommends CADScor System as a first-line diagnostic aid that uses highly sensitive acoustics and computational processing to analyze coronary blood flow to rule out significant coronary artery disease (CAD), with at least 96% certainty at point of care.1

Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX). Erik Penser Bank AB (+46 8 463 83 00, is the Certified Advisor of Acarix.

Learn more
  1. User manual US-FDA v.12.Y, prevalence 10,7%
  2. Shaw LJ, Marwick TH, Zoghbi WA, Hundley WG, Kramer CM, Achenbach S, Dilsizian V, Kern MJ, Chandrashekhar Y, Narula J. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging. 2010 Jul;3(7):789-94. doi: 10.1016/j.jcmg.2010.05.004. PMID: 20633864.
  3. Based on commercial patch use since 2017